SCHEMBL30100697

SCHEMBL30100697

O=C(O)c1ccnc(CC(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 8/20 0.50
KDM5C P41229 7/20 0.50
KDM4A O75164 5/20 0.50
KDM4E B2RXH2 5/20 0.50
KDM5B Q9UGL1 5/20 0.50
KDM6B O15054 4/20 0.50
KDM2A Q9Y2K7 4/20 0.50
KDM3A Q9Y4C1 4/20 0.50
KDM5A P29375 3/20 0.50
KDM4D Q6B0I6 2/20 0.50
ALKBH5 Q6P6C2 2/20 0.50
FTO Q9C0B1 2/20 0.50
TET3 O43151 1/20 0.50
BBOX1 O75936 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
ASPH Q12797 1/20 0.50
TET2 Q6N021 1/20 0.50
KDM7A Q6ZMT4 1/20 0.50
KDM8 Q8N371 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23989390 1.00 KDM4C (0.50) KDM4CKDM5CKDM4AKDM4EKDM5B
SCHEMBL30209656 0.85 CYP1A2 (0.42) KDM4CKDM5CKDM4EKDM5BKDM5A
SCHEMBL28298258 0.85 CYP1A2 (0.39) KDM4CKDM5CKDM4AKDM4EKDM5B
SCHEMBL27850448 0.85 CYP1A2 (0.42) KDM4CKDM5CKDM4EKDM5BKDM5A
SCHEMBL23990564 0.81 KDM4E (0.51) KDM4CKDM5CKDM4EKDM5BKDM6B
SCHEMBL30281068 0.80 KDM4E (0.50) KDM4CKDM5CKDM4EKDM5BKDM6B
SCHEMBL5567317 0.80 ALDH1A1 (0.55) KDM4CKDM5CKDM4AKDM4EKDM5B
SCHEMBL3912359 0.79 KDM4C (0.49) KDM4CKDM5CKDM4AKDM4EKDM5B
SCHEMBL7670706 0.78 KDM4C (0.57) KDM4CKDM5CKDM4AKDM4EKDM5B
SCHEMBL2305108 0.78 KDM4C (0.57) KDM4CKDM5CKDM4AKDM4EKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867348-A Imidazopyrimidines as IL-17 modulators 詹森药业有限公司 2023-03-28 CN disclosed
EP-4143193-A1 IMIDAZOPYRIMIDINES AS MODULATORS OF IL-17 JANSSEN Pharmaceutica NV (BE) 2023-03-08 EP disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed